Granulomatous Vasculitis

Overview

Journal Curr Rheumatol Rep

Publisher Current Science

Specialty Rheumatology

Date 2003 Mar 12

PMID 12628043

Citations 5

Authors

Javier Marquez

Diana Flores

Liliana Candia

Luis R Espinoza

Affiliations

Soon will be listed here.

Abstract

Granulomatous vasculitis is a subset of systemic necrotizing vasculitis and has granulomatous inflammation as the main histopathologic feature. Etiopathogenesis remains poorly understood, although recent advances suggest an important role for certain pro-inflammatory cytokines, such as tumor necrosis factor-alpha. They are a heterogeneous group of clinical disorders with protean manifestations. Serologic abnormalities are present, and the presence of granular cytoplasmic staining-antineutrophil cytoplasmic antibodies is most important and is particularly useful for the diagnosis of active Wegener's granulomatosis. Corticosteroids and cyclophosphamide remain very useful in the treatment of most of these disorders.

Citing Articles

Recurrent Coronary Vasospasm in a 50-Year-Old Woman with Granulomatous Polyangiitis: A Case Report.

Hou L, Zhao J, He T, Luo Y, Su K, Li Y J Inflamm Res. 2024; 17:5285-5291.

PMID: 39157589 PMC: 11329600. DOI: 10.2147/JIR.S472889.

Granulomatous arteritis limited to the skin: case report and etiologic differential diagnosis.

Silva D, Valente N, Oppenheimer A, Oliveira A An Bras Dermatol. 2022; 97(3):400-402.

PMID: 35331600 PMC: 9133301. DOI: 10.1016/j.abd.2020.10.021.

Clinicopathology conference: 41-year-old woman with chronic relapsing meningitis.

Beck E, Ramachandran P, Khan L, Sample H, Zorn K, OConnell E Ann Neurol. 2018; 85(2):161-169.

PMID: 30565288 PMC: 6370480. DOI: 10.1002/ana.25400.

Improvement of Arterial Wall Lesions in Parallel with Decrease of Plasma Pentraxin-3 Levels in a Patient with Refractory Takayasu Arteritis after Treatment with Tocilizumab.

Iwagaitsu S, Naniwa T Case Rep Rheumatol. 2017; 2017:4580967.

PMID: 28676840 PMC: 5476896. DOI: 10.1155/2017/4580967.

Is rituximab superior to cyclophosphamide for ANCA-associated vasculitis for induction of remission, and with a better safety profile?.

Garcia-Valladares I, Espinoza L Curr Rheumatol Rep. 2010; 12(6):395-8.

PMID: 20844995 DOI: 10.1007/s11926-010-0133-y.

References

Koldingsnes W, Nossent H . Predictors of survival and organ damage in Wegener's granulomatosis. Rheumatology (Oxford). 2002; 41(5):572-81. DOI: 10.1093/rheumatology/41.5.572. View

Weyand C, Goronzy J . Pathogenic mechanisms in giant cell arteritis. Cleve Clin J Med. 2002; 69 Suppl 2:SII28-32. DOI: 10.3949/ccjm.69.suppl_2.sii28. View

Chevalet P, Barrier J, Pottier P, Magadur-Joly G, Pottier M, Hamidou M . A randomized, multicenter, controlled trial using intravenous pulses of methylprednisolone in the initial treatment of simple forms of giant cell arteritis: a one year followup study of 164 patients. J Rheumatol. 2000; 27(6):1484-91. View

Giordano J . Surgical treatment of Takayasu's disease. Cleve Clin J Med. 2002; 69 Suppl 2:SII146-8. DOI: 10.3949/ccjm.69.suppl_2.sii146. View

Hoffman G, Ahmed A . Surrogate markers of disease activity in patients with Takayasu arteritis. A preliminary report from The International Network for the Study of the Systemic Vasculitides (INSSYS). Int J Cardiol. 1999; 66 Suppl 1:S191-4; discussion S195. DOI: 10.1016/s0167-5273(98)00181-8. View

Numano F . The story of Takayasu arteritis. Rheumatology (Oxford). 2002; 41(1):103-6. DOI: 10.1093/rheumatology/41.1.103. View

Leavitt R, Fauci A, Bloch D, Michel B, Hunder G, Arend W . The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum. 1990; 33(8):1101-7. DOI: 10.1002/art.1780330807. View

Guilpain P, Viallard J, Lagarde P, Cohen P, Kambouchner M, Pellegrin J . Churg-Strauss syndrome in two patients receiving montelukast. Rheumatology (Oxford). 2002; 41(5):535-9. DOI: 10.1093/rheumatology/41.5.535. View

Gonzalez-Gay M, Garcia-Porrua C, Llorca J, Hajeer A, Branas F, Dababneh A . Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients. Medicine (Baltimore). 2000; 79(5):283-92. DOI: 10.1097/00005792-200009000-00001. View

10.

Solans R, Bosch J, Perez-Bocanegra C, Selva A, Huguet P, Alijotas J . Churg-Strauss syndrome: outcome and long-term follow-up of 32 patients. Rheumatology (Oxford). 2001; 40(7):763-71. DOI: 10.1093/rheumatology/40.7.763. View

11.

Schmidt W, Nerenheim A, Seipelt E, Poehls C, Gromnica-Ihle E . Diagnosis of early Takayasu arteritis with sonography. Rheumatology (Oxford). 2002; 41(5):496-502. DOI: 10.1093/rheumatology/41.5.496. View

12.

Sneller M . Granuloma formation, implications for the pathogenesis of vasculitis. Cleve Clin J Med. 2002; 69 Suppl 2:SII40-3. DOI: 10.3949/ccjm.69.suppl_2.sii40. View

13.

Gonzalez-Gay M, Garcia-Porrua C . Systemic vasculitis in adults in northwestern Spain, 1988-1997. Clinical and epidemiologic aspects. Medicine (Baltimore). 1999; 78(5):292-308. DOI: 10.1097/00005792-199909000-00002. View

14.

Csernok E, Trabandt A, Muller A, Wang G, Moosig F, Paulsen J . Cytokine profiles in Wegener's granulomatosis: predominance of type 1 (Th1) in the granulomatous inflammation. Arthritis Rheum. 1999; 42(4):742-50. DOI: 10.1002/1529-0131(199904)42:4<742::AID-ANR18>3.0.CO;2-I. View

15.

Naides S . Known causes of vasculitis in man. Cleve Clin J Med. 2002; 69 Suppl 2:SII15-9. DOI: 10.3949/ccjm.69.suppl_2.sii15. View

16.

Weyand C, Goronzy J . Arterial wall injury in giant cell arteritis. Arthritis Rheum. 1999; 42(5):844-53. DOI: 10.1002/1529-0131(199905)42:5<844::AID-ANR2>3.0.CO;2-M. View

17.

Espinoza L . Renal outcome in Wegener's granulomatosis. Curr Rheumatol Rep. 2002; 4(1):7-8. DOI: 10.1007/s11926-002-0017-x. View

18.

Regan M, Wood B, Hsieh Y, Theodore M, Quinn T, Hellmann D . Temporal arteritis and Chlamydia pneumoniae: failure to detect the organism by polymerase chain reaction in ninety cases and ninety controls. Arthritis Rheum. 2002; 46(4):1056-60. DOI: 10.1002/art.517. View

19.

Cuchacovich R . Immunopathogenesis of vasculitis. Curr Rheumatol Rep. 2002; 4(1):9-17. DOI: 10.1007/s11926-002-0018-9. View

20.

Stone J . Targeted therapies in systemic vasculitis. Cleve Clin J Med. 2002; 69 Suppl 2:SII124-8. DOI: 10.3949/ccjm.69.suppl_2.sii124. View